BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Critical Therapeutics, Inc. 

60 Westview Street

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-402-5700 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

MedImmune 





 Company News
Critical Therapeutics, Inc. (CRTX) Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma, Inc. and 10-to-1 Reverse Stock Split 10/31/2008 11:16:58 AM
Critical Therapeutics, Inc. (CRTX) Reports Financial Results for the Third Quarter Ended September 30, 2008 10/21/2008 10:28:01 AM
Critical Therapeutics, Inc. (CRTX) Announces Effectiveness Of Registration Statement For The Proposed Merger With Cornerstone BioPharma, Inc. 10/6/2008 10:53:23 AM
Critical Therapeutics, Inc. (CRTX) Receives Notice of Additional Deficiency from NASDAQ 8/14/2008 11:25:16 PM
Critical Therapeutics, Inc. (CRTX) Reports Financial Results for the Second Quarter Ended June 30, 2008 8/11/2008 11:00:52 PM
Critical Therapeutics, Inc. (CRTX) to Report Second Quarter 2008 Financial Results on August 11 8/7/2008 8:45:47 AM
Critical Therapeutics, Inc. (CRTX) Files Registration Statement on Form S-4 with Securities and Exchange Commission 7/22/2008 9:13:41 AM
Critical Therapeutics, Inc. (CRTX) Announces Stock Listing Transfer From NASDAQ Global Market to NASDAQ Capital Market 6/17/2008 11:14:58 AM
Critical Therapeutics, Inc. (CRTX) Completes Phase II Clinical Trial for Zileuton Injection 6/3/2008 8:50:18 AM
Critical Therapeutics, Inc. (CRTX) Receives Notice of Additional Deficiency from NASDAQ 5/21/2008 8:45:08 AM
12345678910...